Vaccines for treatment of COVID-19
| Developer | Name of vaccine | Type of vaccine | Target antigen |
|---|---|---|---|
| Sinopharm | BBIBP-CorV | Inactivated virus | Whole virus |
| Sinovac Biotech | CoronaVac | Inactivated virus | Whole virus |
| Bharat Biotech | Covaxin | Inactivated virus | Whole virus |
| University of Oxford and AstraZeneca | AZD1222 | Chimpanzee adenoviral vector | S protein |
| Janssen and Johnson & Johnson | Ad26.CoV2.S | Human adenoviral vector | S protein |
| Gamaleya | Sputnik V | Human adenoviral vectors (two serotypes) | S protein |
| Moderna and NIAD | mRNA-1273 | mRNA | S protein |
| Pfizer and BioNTech | BNT162b2 | mRNA | S protein |
| Novavax and CEPI | NVX-CoV-2373 | Protein subunit | S protein |
| Bharat Biotech | BBV154 (1st intranasal vaccine) | Recombinant adenoviral vector | S protein |